The Cooper Companies, Inc.(品牌名為 CooperCompanies)是一家全球醫療器械公司,總部設於加利福尼亞州聖拉蒙。
財務指標
營業收入
2026-07-31
$1.06B
2026-04-30
$1.08B
2026-01-31
$1.02B
2025-10-31
$1.06B
營業支出
2026-07-31
$442.5M
2026-04-30
$766.4M
2026-01-31
$482.4M
2025-10-31
$460.6M
淨利潤
2026-07-31
$432.8M
2026-04-30
-$77.9M
2026-01-31
$130.8M
2025-10-31
$84.6M
淨利潤率
2026-07-31
40.59%
2026-04-30
-7.2%
2026-01-31
12.77%
2025-10-31
7.94%
每股收益
2026-07-31
$1.15
2026-04-30
$1.21
2026-01-31
$1.10
2025-10-31
$1.15
息稅折舊攤銷前利潤
2026-07-31
$317.1M
2026-04-30
$67.9M
2026-01-31
$310.1M
2025-10-31
$215.2M
有效稅率
2026-07-31
-114.47%
2026-04-30
-60.95%
2026-01-31
31.94%
2025-10-31
27.56%
項目
2026-07-31
2026-04-30
2026-01-31
2025-10-31
營業收入
$1.06B
$1.08B
$1.02B
$1.06B
營業支出
$442.5M
$766.4M
$482.4M
$460.6M
淨利潤
$432.8M
-$77.9M
$130.8M
$84.6M
淨利潤率
40.59%
-7.2%
12.77%
7.94%
每股收益
$1.15
$1.21
$1.10
$1.15
息稅折舊攤銷前利潤
$317.1M
$67.9M
$310.1M
$215.2M
有效稅率
-114.47%
-60.95%
31.94%
27.56%
常見問題
COO is the ticker symbol for The Cooper Companies, Inc., a U.S.-based medical device company traded on the Nasdaq. It operates primarily through two segments: CooperVision, which makes contact lenses, and CooperSurgical, which provides medical devices and fertility products for women's health. The company is listed on major U.S. exchanges and is part of the healthcare sector. Because COO is a specific corporate ticker, it is distinct from other securities that may use similar symbols. This makes it important to confirm the exact listing on the page.
The current price of COO stock changes throughout each trading session, so no fixed number can be stated here. For the latest price, refer to the live quote displayed at the top of this stock detail page, which reflects the most recent trade. That figure also shows the day's change and other timely data. Because prices update in real time, checking the page is the most reliable way to see where COO is trading at any given moment.
Recent performance for COO depends on the exact time frame being reviewed. The stock detail page provides up-to-date performance figures, including daily, weekly, and longer-term changes, so users can see how the shares have moved lately. These figures reflect actual market activity and may differ based on the period selected. For the most current and specific performance data on COO, consult the latest quote and performance section shown on this page rather than relying on a static figure.
Evaluating COO's valuation involves reviewing metrics such as the price-to-earnings ratio, price-to-sales, and enterprise value multiples, alongside comparisons to peers in the medical device and healthcare sector. Growth expectations, margins, and cash flow also matter. Because these figures change as the stock price and financial results update, the most accurate way to assess COO's valuation is to check the latest data displayed on this page, which may include current multiples and other relevant valuation measures.
COO shares can be traded outside standard U.S. market hours through pre-market and after-hours sessions, but these windows are generally subject to lower liquidity and wider spreads than the regular session. Participation may be limited by the rules of the exchange or brokerage being used, and not all platforms support extended-hours trading for every security. For specific session times and availability, investors should review the trading information provided on this page or their broker's schedule.
The Cooper Companies, Inc. has historically not paid a regular cash dividend on its common stock. Instead, the company has generally retained earnings to fund operations, acquisitions, and other corporate needs. Dividend policies can change over time, so the most reliable way to confirm whether COO currently pays a dividend, and at what rate, is to check the dividend information displayed on this stock detail page, which reflects the latest available company data.